LEUKEMIA INHIBITORY FACTOR EXPRESSION IN CULTURED RAT ANTERIOR-PITUITARY IS REGULATED BY GLUCOCORTICOIDS

被引:13
作者
CARTER, DA
机构
[1] Physiology Unit, School of Molecular and Medical Biosciences, University of Wales, Cardiff, CF1 3US
关键词
LEUKEMIA INHIBITORY FACTOR; PITUITARY; GLUCOCORTICOIDS; DEXAMETHASONE; CYTOKINES;
D O I
10.1111/j.1365-2826.1995.tb00800.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leukaemia inhibitory factor (LIF) is the generally recognized nomenclature for a pleiotropic cytokine that exerts multiple biological effects in different systems. However, its role in the neuroendocrine system is relatively unexplored, with the exception of one report indicating that LIF may act to determine the unique vascular organization of the pituitary gland. In the present study the expression of LIF mRNA has been demonstrated for the first time in the pituitary gland of the rat, in all three pituitary lobes. However, LIF gene expression is restricted to tissues in explant culture where LIF transcripts are readily detectable by Northern Techniques. Similar studies using the reverse transcriptase-polymerase chain reaction (RT-PCR) technique also failed to detect LIF transcripts in fresh tissue from adult animals, These results are consistent with the hypothesis that LIF acts to mediate the response to trauma, a response that may include the induction of neuropeptide expression in the anterior pituitary. In further studies it has also been shown that anterior pituitary LIF mRNA is super-induced in the presence of protein synthesis inhibitors, a response that indicates a role for a labile protein in the attentuation of LIF expression. Both the explantation response, and the response to protein synthesis inhibitory drugs are decreased in the presence of dexamethasone indicating that a glucocorticoid receptor mechanism acts as a general modulatory influence on LIF mRNA levels. These findings are consistent with the presence of multiple regulatory controls on the expression of LIF that serve to restrict its expression to pathological conditions, and indicate that LIF does not participate in normal endocrine physiology.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 30 条
[21]  
Sambrook J., 1989, MOL CLONING LAB MANU
[22]   INTERLEUKIN-1 INDUCES SUBSTANCE-P IN SYMPATHETIC-GANGLIA THROUGH THE INDUCTION OF LEUKEMIA INHIBITORY FACTOR (LIF) [J].
SHADIACK, AM ;
HART, RP ;
CARLSON, CD ;
JONAKAIT, GM .
JOURNAL OF NEUROSCIENCE, 1993, 13 (06) :2601-2609
[23]   ENDOTOXIN-INDUCED RELEASE OF INTERLEUKIN-6 FROM RAT MEDIAL BASAL HYPOTHALAMI [J].
SPANGELO, BL ;
JUDD, AM ;
MACLEOD, RM ;
GOODMAN, DW ;
ISAKSON, PC .
ENDOCRINOLOGY, 1990, 127 (04) :1779-1785
[24]   BLASTOCYST IMPLANTATION DEPENDS ON MATERNAL EXPRESSION OF LEUKEMIA INHIBITORY FACTOR [J].
STEWART, CL ;
KASPAR, P ;
BRUNET, LJ ;
BHATT, H ;
GADI, I ;
KONTGEN, F ;
ABBONDANZO, SJ .
NATURE, 1992, 359 (6390) :76-79
[25]   STAT PROTEINS PARTICIPATE IN THE REGULATION OF THE VASOACTIVE-INTESTINAL-PEPTIDE GENE BY THE CILIARY NEUROTROPHIC FACTOR FAMILY OF CYTOKINES [J].
SYMES, A ;
LEWIS, S ;
CORPUS, L ;
RAJAN, P ;
HYMAN, SE ;
FINK, JS .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (12) :1750-1763
[26]   PRODUCTION OF INTERLEUKIN-6 BY FOLLICULO-STELLATE CELLS OF THE ANTERIOR-PITUITARY GLAND IN A HISTIOTYPIC CELL AGGREGATE CULTURE SYSTEM [J].
VANKELECOM, H ;
CARMELIET, P ;
VANDAMME, J ;
BILLIAU, A ;
DENEF, C .
NEUROENDOCRINOLOGY, 1989, 49 (01) :102-106
[27]   CROSS-SPECIES COMPARISON OF THE SEQUENCE OF THE LEUKEMIA INHIBITORY FACTOR GENE AND ITS PROTEIN [J].
WILLSON, TA ;
METCALF, D ;
GOUGH, NM .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 204 (01) :21-30
[28]   LOCALIZATION OF CHOLINERGIC DIFFERENTIATION FACTOR LEUKEMIA INHIBITORY FACTOR MESSENGER-RNA IN THE RAT-BRAIN AND PERIPHERAL-TISSUES [J].
YAMAMORI, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (16) :7298-7302
[29]   THE CHOLINERGIC NEURONAL DIFFERENTIATION FACTOR FROM HEART-CELLS IS IDENTICAL TO LEUKEMIA INHIBITORY FACTOR [J].
YAMAMORI, T ;
FUKADA, K ;
AEBERSOLD, R ;
KORSCHING, S ;
FANN, MJ ;
PATTERSON, PH .
SCIENCE, 1989, 246 (4936) :1412-1416
[30]  
ZIMMERMANN J, 1994, BIOTECHNIQUES, V17, P302